PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
18778688-2	2008	Here we identified a new oleanolic acid derivative, 3-beta-(2-carboxybenzoyloxy)-oleanolic acid (NPLC441), which functioned as a competitive PTP1B inhibitor and enhanced insulin-stimulated phosphorylation of IR and AKT in HepG2 cells.	Oleanolic Acid	25-39	insulin	Homo sapiens	170-177	
26843885-0	2015	Oleanolic Acid Attenuates Insulin Resistance via NF-kappaB to Regulate the IRS1-GLUT4 Pathway in HepG2 Cells.	Oleanolic Acid	0-14	insulin	Homo sapiens	26-33	
26843885-1	2015	The aim of our study is to elucidate the mechanisms of oleanolic acid (OA) on insulin resistance (IR) in HepG2 cells.	Oleanolic Acid	55-69	insulin	Homo sapiens	78-85	
26843885-1	2015	The aim of our study is to elucidate the mechanisms of oleanolic acid (OA) on insulin resistance (IR) in HepG2 cells.	Oleanolic Acid	71-73	insulin	Homo sapiens	78-85	
23531458-1	2013	Twenty-four sugar-substituted oleanolic acid derivatives (1a-1f, 2a-2j, and 3a-3h) were synthesized in a concise and efficient strategy and their effects on the inhibition of protein tyrosine phosphatase 1B (PTP1B) and insulin-sensitizing response were evaluated in vitro.	Oleanolic Acid	30-44	insulin	Homo sapiens	219-226	
23531458-4	2013	Structure-activity relationship study of these sugar-substituted oleanolic acid derivatives demonstrated that PTP1B inhibitory activity and insulin-sensitizing response were strongly influenced by both the carbohydrate moiety at the C-3 position and the long acidic chain at C-28 position of oleanolic acid.	Oleanolic Acid	65-79	insulin	Homo sapiens	140-147